CubeSmart vs Humana Inc — how do they compare? CubeSmart trades at $37.93 (market cap $8.45B), while Humana Inc trades at $436 (market cap $46.49B). The key difference: Humana Inc is far larger — about 5.5× CubeSmart's market cap, and CubeSmart pays the higher dividend (5.65%). Which is the better fit depends on your goals — on Pluang, investors hold CubeSmart for 89 Days and Humana Inc for 51 Days on average.
| CUBE | HUM | |
|---|---|---|
Market Cap | $8.45B | $46.49B |
Volume | 2,879,532 | 2,567,704 |
Sector | Real Estate | Health |
52-Week High | $42.50 | $409.85 |
52-Week Low | $35.36 | $163.67 |
Typical Hold Time | 89 Days | 51 Days |
Enterprise Value | $11.97B | $53.84B |
Dividend Yield | 5.65% | 0.91% |
Signals from Pluang's Aura AI — not financial advice
CubeSmart (CUBE) trades at $37.97, up 1.99% on the day, with a bearish technical outlook as moving averages signal selling pressure. The company reported mixed Q2 2026 results, with an FFO miss but revenue beat, and maintains strong profitability with a 29.41% net income margin. Recent news highlights institutional accumulation, with firms like NewEdge Advisors and Deutsche Bank increasing stakes, while analyst consensus leans toward Hold with a $44.00 price target.
The stock offers a 5.4% dividend yield and trades below the consensus target, suggesting potential upside if operational improvements materialize. Risks include high leverage with $2.99B in long-term debt and sensitivity to real estate market cycles. Earnings growth in H2 2026 is critical for reversing the current bearish sentiment.
Humana (HUM) trades at $431.03, up 8.71% over the past day, reflecting strong momentum following a Barclays upgrade and positive earnings beats. The stock exhibits a bullish technical trend, with support at $378 and resistance at $394. Revenue has grown steadily from $92.9B in 2022 to $129.7B in 2025, though net income margins have compressed to 0.88%. Analyst consensus is a Buy with a $457.05 price target, and recent news highlights corporate initiatives and institutional investments.
The outlook for HUM is cautiously optimistic, driven by revenue growth and analyst support, but risks include margin pressure and regulatory scrutiny. Investment opportunity lies in execution of Medicare Advantage strategies, while key risks involve competitive pressures and potential fiduciary concerns highlighted in recent shareholder notices.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Most of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. CubeSmart derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.
Read more on CUBE →Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →